Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01178333 · ClinicalTrials.gov registry record
Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
A clinical trial, sponsored by Carelon Research.
- Completed
- Registry status
- 668
- Enrollment target
NCT01178333 is a clinical trial that has completed, run by Carelon Research. The registered enrollment target is 668 participants.
The verdict
NCT01178333 has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- 668 participants
- Enrollment target
Study Summary
HIT-RADIO is a study of patients who had a positive heparin PF-4 antibody test between 1/21/2008 and 9/25/2008 at selected hospitals. The study will collect and analyse information that is already in the patients' medical records. Information about laboratory values (such as platelet counts), treatments (such as medications), and outcomes (such as blood clots, amputation, and death) will be included.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 668 participants |
| Start Date | 2010-06 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01178333
The ClinicalTrials.gov registry entry for NCT01178333 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 668 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01178333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01178333 about?
NCT01178333 is a clinical study titled "Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study". HIT-RADIO is a study of patients who had a positive heparin PF-4 antibody test between 1/21/2008 and 9/25/2008 at selected hospitals. The study will collect and analyse information that is already in the patients' medical records. Information about laboratory values (such as platelet counts), treatm...
What is the current status of trial NCT01178333?
This trial is currently completed. The enrollment target is 668 participants. The study started on 2010-06. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01178333?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.